glp-1 news today Can one drug do it all? Reviewing the expanding clinical universe of agonists GLP-1 receptor agonists show promise
Description
The potential of this approach was recently demonstrated by the extraordinary weight loss achieved by tirzepatide, a GLP-1/GIP receptor dual agonist
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascularrisk in type 2 diabetes mellitus
Its important to think about possible side effects and talk to a healthcare provider if needed
Data from January 2021 through May 2023 Source: IQVIA LAAD pharmacy and medical claims
Insulin resistance also disrupts the hypothalamicpituitarygonadal axis
Concerns have been raised that the rate of DKA in real-world practice would surpass rates seen in closely supervised RCTs [37]
